Deepti Agrawal

4PUBLICATIONS
30CO-AUTHORS
Molecular targetsRegenerative medicine (incl. stem cells)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 21, 2026
Aberrant methylation limits antitumoral inflammation in lung adenocarcinoma by restricting RIPK3 expression.

Deepti Agrawal, Katarina Cisarova, Sebastian Vosberg

|Jul 01, 2021
Correction: MLKL promotes cellular differentiation in myeloid leukemia by facilitating the release of G-CSF.

Xin Wang, Uris Ros, Deepti Agrawal

|Jun 03, 2021
MLKL promotes cellular differentiation in myeloid leukemia by facilitating the release of G-CSF.

Xin Wang, Uris Ros, Deepti Agrawal

|Sep 11, 2020
MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeutically.

Enkhtsetseg Munkhbaatar, Michelle Dietzen, Deepti Agrawal

Pageof 1